Ramosetron on Late PONV (Postoperative Nausea and Vomiting)
Status:
Completed
Trial end date:
2021-10-31
Target enrollment:
Participant gender:
Summary
The purpose of this study was to evaluate the effectiveness of additional ramosetron
injection for controlling late postoperative nausea and vomiting (PONV) after breast surgery
in high risk PONV patients. The investigators compared PONV amomng 3 groups- group C: no
additional ramosteron, group B: two additional ramosteron doses at 12 hour interval, group M:
two additional ramosetron doses mix to the intraveonus patient controlled analgesia.